Entia Biosciences, Inc. — key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2016)

$265.5K

Net Income/Loss (FY2016)

-$1.4M

Total Assets (FY2016)

$439.1K

Total Equity (FY2016)

-$2.0M

Cash Flows from Operating Activities (FY2016)

-$715.1K

Source: Entia Biosciences, Inc. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.